RS
OFIX icon

R Squared’s Orthofix Medical OFIX Stock Holding History

R Squared’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,518
Closed -$155K – 646
2026
Q1 		$155K Buy
13,518
+904
+7% +$11.9K 0.09% 329
2025
Q4 		$191K Buy
+12,614
New +$193K 0.09% 373
2025
Q1 		– Sell
-2,850
Closed -$49.8K – 1106
2024
Q4 		$49.8K Buy
+2,850
New +$49.6K 0.05% 496

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

R Squared's OFIX Position: Q2 2026 in Review

R Squared sold out of Orthofix Medical (OFIX) in Q2 2026, closing a stake of 13,518 shares — an estimated $155K sold.

R Squared first reported a position in OFIX in Q4 2024 and held it in 3 quarters. The position peaked at $191K in Q4 2025. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • R Squared reported no remaining Orthofix Medical position as of Q2 2026 after selling out during the quarter.
  • R Squared sold 13,518 Orthofix Medical shares in Q2 2026, an estimated $155K.
  • R Squared first reported a position in Orthofix Medical in Q4 2024 and held it in 3 quarters.
  • R Squared's Orthofix Medical position peaked at $191K in Q4 2025.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.